- Home
- TLK vs NBIX Comparison
TLK vs NBIX Comparison
Compare TLK & NBIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLK
- NBIX
- Stock Information
- Founded
- TLK 1884
- NBIX 1992
- Country
- TLK Indonesia
- NBIX United States
- Employees
- TLK N/A
- NBIX N/A
- Industry
- TLK Telecommunications Equipment
- NBIX Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- TLK Telecommunications
- NBIX Health Care
- Exchange
- TLK Nasdaq
- NBIX Nasdaq
- Market Cap
- TLK 16.1B
- NBIX 13.2B
- IPO Year
- TLK 1995
- NBIX 1996
- Fundamental
- Price
- TLK $19.39
- NBIX $139.60
- Analyst Decision
- TLK
- NBIX Strong Buy
- Analyst Count
- TLK 0
- NBIX 18
- Target Price
- TLK N/A
- NBIX $160.94
- AVG Volume (30 Days)
- TLK 840.5K
- NBIX 782.5K
- Earning Date
- TLK 10-29-2025
- NBIX 10-29-2025
- Dividend Yield
- TLK 5.40%
- NBIX N/A
- EPS Growth
- TLK N/A
- NBIX 2.97
- EPS
- TLK 0.01
- NBIX 3.39
- Revenue
- TLK $9,097,469,437.00
- NBIX $2,509,900,000.00
- Revenue This Year
- TLK $1.88
- NBIX $20.66
- Revenue Next Year
- TLK $3.04
- NBIX $14.64
- P/E Ratio
- TLK $13.47
- NBIX $40.91
- Revenue Growth
- TLK N/A
- NBIX 18.42
- 52 Week Low
- TLK $13.15
- NBIX $84.23
- 52 Week High
- TLK $21.00
- NBIX $154.61
- Technical
- Relative Strength Index (RSI)
- TLK 57.33
- NBIX 68.09
- Support Level
- TLK $19.62
- NBIX $133.62
- Resistance Level
- TLK $19.59
- NBIX $137.03
- Average True Range (ATR)
- TLK 0.33
- NBIX 2.36
- MACD
- TLK -0.11
- NBIX 0.83
- Stochastic Oscillator
- TLK 19.29
- NBIX 97.44
About TLK PT Telekomunikasi Indonesia Tbk
PT Telkom Indonesia (Persero) Tbk is the integrated telecommunications provider in Indonesia. The company is focusing on dividing business into 3 Digital Business Domains namely, digital connectivity, digital platform, and digital services. It also provides a wide range of other communication services, including telephone network, interconnection services, multimedia, data and internet communication-related services, satellite transponder leasing, leased line, intelligent network and related services, cable television, and VoIP services. The group derives revenue from product lines: Mobile, Consumer, Enterprise, WIB and Others.
About NBIX Neurocrine Biosciences Inc.
Neurocrine Biosciences Inc engages in the discovery, development, and commercialization of drugs for the treatment of neurological and endocrine-related diseases and disorders in the United States. The company's products include INGREZZA for tardive dyskinesia and chorea associated with Huntington's disease; ALKINDI for adrenal insufficiency; Efmody capsules for classic congenital adrenal hyperplasia; Orilissa tablets for endometriosis; and Oriahnn capsules to treat uterine fibroids.